证券代码：002317 公告编号：2025-078 广东众生药业股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 性股票数量为 162.6000 万股，占回购注销前公司总股本的 0.19%。本次回购注销 涉及 72 名激励对象，回购价格为 4.78 元/股。本次回购注销完成后，公司股份总 数为 849,930,477 股。 司深圳分公司办理完成注销手续。 一、本次股权激励计划相关情况介绍 （一）2022 年 2 月 11 日，公司第七届董事会第十六次会议审议通过了《关 于 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划" 草案="草案"> 及其摘要的议 案》《关于 <公司> 权董事会办理股权激励相关事宜的议案》，公司第七届监事会第九次会议审议通 过了相关议案。公司独立董事发表了同意的独立意见。公司聘请的北京海润天睿 律师事务所对 2022 年限制性股票激励计划（以下简称"激励计划"、"本激励 计划"）相关事项出具了法律意见书。 （二）2022 年 2 月 14 日至 2022 年 2 月 23 日，公司对本 ...

证券日报网讯 7月30日晚间，众生药业发布公告称，公司本次回购注销的限制性股票数量为162.6000万 股，占回购注销前公司总股本的0.19%。本次回购注销涉及72名激励对象，回购价格为4.78元/股。本次 回购注销完成后，公司股份总数为849，930，477股。截至本公告披露日，上述限制性股票已在中国证 券登记结算有限责任公司深圳分公司办理完成注销手续。 （文章来源：证券日报） ...

证券代码：002317 公告编号：2025-078 广东众生药业股份有限公司 关于限制性股票回购注销完成的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、广东众生药业股份有限公司（以下简称"公司"）本次回购注销的限制 性股票数量为 162.6000 万股，占回购注销前公司总股本的 0.19%。本次回购注销 涉及 72 名激励对象，回购价格为 4.78 元/股。本次回购注销完成后，公司股份总 数为 849,930,477 股。 2、截至本公告披露日，上述限制性股票已在中国证券登记结算有限责任公 司深圳分公司办理完成注销手续。 证券代码：002317 公告编号：2025-078 （三）2022 年 3 月 1 日，公司 2022 年第一次临时股东大会审议通过了《关 于<公司 2022 年限制性股票激励计划（草案）>及其摘要的议案》《关于<公司 2022 年限制性股票激励计划实施考核管理办法>的议案》《关于提请股东大会授 权董事会办理股权激励相关事宜的议案》。公司实施本激励计划获得批准，董事 会被授权确定授予日、在激励对象符合条件时向激励对象授 ...

Market Overview - The indices continued to rise collectively, with a significant drop in the morning followed by a recovery in sentiment in the afternoon [3] - The Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index closed up by 0.33%, 0.64%, and 1.86% respectively, with over 3,000 stocks declining and more than 2,200 stocks rising [4] Optimizing Fertility - The "Implementation Plan for Childcare Subsidy System" was officially launched, providing annual subsidies of 3,600 yuan per child for children under three years old starting January 1, 2025 [8] - The fertility optimization sector saw a collective high opening but ended with a "high open low close" trend, with the sector rising by only 0.18% after an initial surge [9][10] - Stocks like Beiyinmei and Aiyingshi opened strongly but fell significantly, while stocks in the dairy sector also experienced a similar pattern [10] Yajiang Hydropower Station - The Yajiang Hydropower Station saw a rebound in the afternoon, with stocks like Xining Special Steel and Tibet Tianlu hitting the daily limit [15] - The Yajiang Hydropower concept stocks rose over 2% by the end of the day, indicating a recovery in investor interest [14] Stablecoin Sector - The stablecoin concept stocks experienced a partial rebound, with companies like Hengbao Co. and Sifang Jichuang showing strong performance [19] - The sector had been quiet for about two weeks but is now looking for a significant catalyst to revive interest [21] Guotou Intelligent - Guotou Intelligent saw a significant rise, closing up over 18.5%, attributed to news regarding a special action by the Internet Information Office [25] - The company is reportedly working on AI fraud prevention services, with a potential market space exceeding 120 billion yuan if it covers 1 billion smartphone users [28]

（原标题：众生药业龙虎榜数据（7月29日）） 众生药业今日涨停，全天换手率15.34%，成交额22.60亿元，振幅10.78%。龙虎榜数据显示，机构净买 入8309.12万元，深股通净买入6267.61万元，营业部席位合计净买入3514.45万元。 资金流向方面，今日该股主力资金净流入3.03亿元，其中，特大单净流入2.64亿元，大单资金净流入 3821.06万元。近5日主力资金净流入3.48亿元。 融资融券数据显示，该股最新（7月28日）两融余额为6.37亿元，其中，融资余额为6.34亿元，融券余额 为303.01万元。近5日融资余额合计减少184.10万元，降幅为0.29%，融券余额合计增加17.52万元，增幅 6.14%。（数据宝） | 买/卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 深股通专用 | 18509.35 | 12241.74 | | 买二 | 机构专用 | 7271.60 | 1783.10 | | 买三 | 国泰海通证券股份有限公司宜昌沿江大道证券营业部 | 6186.13 | 20.47 | ...

Market Overview - The Shanghai Composite Index rose by 0.33% on July 29, with 16 out of 28 sectors experiencing gains, led by the communication and steel industries, which increased by 3.29% and 2.59% respectively [1] - The pharmaceutical and biological industry ranked third in terms of daily gains, rising by 2.06% [1] - Conversely, the agriculture, forestry, animal husbandry, and fishery sectors, along with the banking sector, saw declines of 1.36% and 1.19% respectively [1] Capital Flow Analysis - The net outflow of capital from the two markets reached 35.637 billion yuan, with only four sectors experiencing net inflows [1] - The pharmaceutical and biological sector led the net inflow with 2.996 billion yuan, followed by the steel sector with a net inflow of 419 million yuan [1] - The non-ferrous metals sector had the highest net outflow, totaling 4.434 billion yuan, followed by the machinery equipment sector with a net outflow of 3.792 billion yuan [1] Pharmaceutical and Biological Sector Performance - The pharmaceutical and biological sector saw a net inflow of 2.996 billion yuan, with 341 out of 474 stocks in the sector rising, including 11 stocks hitting the daily limit [2] - The top three stocks with the highest net inflow were: - Zhongsheng Pharmaceutical with a net inflow of 303 million yuan and a daily increase of 9.98% - Zhifei Biological with a net inflow of 256 million yuan and a daily increase of 6.50% - Jiuzhou Pharmaceutical with a net inflow of 250 million yuan and a daily increase of 10.01% [2] - Seven stocks in the sector experienced net outflows exceeding 100 million yuan, with the largest outflows from: - Hengrui Medicine at 352 million yuan - Saili Medical at 187 million yuan - WuXi AppTec at 173 million yuan [2][4] Capital Inflow and Outflow Rankings - The top stocks by capital inflow in the pharmaceutical sector included: - Zhongsheng Pharmaceutical: +9.98%, turnover rate 15.34%, inflow 302.59 million yuan - Zhifei Biological: +6.50%, turnover rate 9.19%, inflow 255.84 million yuan - Jiuzhou Pharmaceutical: +10.01%, turnover rate 12.54%, inflow 249.88 million yuan [2] - The top stocks by capital outflow included: - Hengrui Medicine: +2.84%, turnover rate 2.64%, outflow -352.45 million yuan - Saili Medical: -4.62%, turnover rate 28.21%, outflow -186.81 million yuan - WuXi AppTec: +7.72%, turnover rate 3.78%, outflow -173.05 million yuan [4]

今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | CRO概念 | 4.00 | 猪肉 | -1.35 | | 重组蛋白 | 2.90 | 养鸡 | -1.12 | | 创新药 | 2.79 | 草甘膦 | -1.10 | | 减肥药 | 2.76 | 粮食概念 | -1.00 | | F5G概念 | 2.43 | 芬太尼 | -0.88 | | 细胞免疫治疗 | 2.42 | PEEK材料 | -0.85 | | 仿制药一致性评价 | 2.30 | 预制菜 | -0.85 | | 共封装光学(CPO) | 2.23 | 生态农业 | -0.78 | | 特钢概念 | 2.08 | C2M概念 | -0.78 | | 先进封装 | 1.91 | 人造肉 | -0.76 | 截至7月29日收盘，仿制药一致性评价概念上涨2.30%，位居概念板块涨幅第7，板块内，104股上涨， 亚太药业、九洲药业、辰欣药业等涨停，南新制药、苑东生物、海特生物等涨幅居前，分别上涨 17.01%、15.45%、15.28%。跌幅居前的有昂 ...

减肥药概念资金流入榜 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 002317 | 众生药 业 | 9.98 | 15.34 | 30259.16 | 13.39 | | 300122 | 智飞生 物 | 6.50 | 9.19 | 25584.13 | 8.11 | | 300765 | 新诺威 | 7.10 | 1.03 | 9329.48 | 13.00 | | 002294 | 信立泰 | 3.68 | 1.39 | 9194.53 | 11.73 | | 002038 | 双鹭药 业 | 7.09 | 9.67 | 7891.35 | 11.45 | | 002821 | 凯莱英 | 4.13 | 4.86 | 7719.47 | 4.12 | | 300199 | 翰宇药 业 | 4.97 | 21.02 | 7338.57 | 2.48 | | 000513 | 丽珠集 | 0.07 | 3.00 | ...

截至7月29日收盘，创新药概念上涨2.79%，位居概念板块涨幅第3，板块内，195股上涨，睿智医药20% 涨停，奥翔药业、亚太药业、九洲药业等涨停，三元基因、药石科技、南新制药等涨幅居前，分别上涨 20.76%、18.77%、17.01%。跌幅居前的有昂利康、*ST苏吴、多瑞医药等，分别下跌6.16%、5.04%、 4.66%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | CRO概念 | 4.00 | 猪肉 | -1.35 | | 重组蛋白 | 2.90 | 养鸡 | -1.12 | | 创新药 | 2.79 | 草甘膦 | -1.10 | | 减肥药 | 2.76 | 粮食概念 | -1.00 | | F5G概念 | 2.43 | 芬太尼 | -0.88 | | 细胞免疫治疗 | 2.42 | PEEK材料 | -0.85 | | 仿制药一致性评价 | 2.30 | 预制菜 | -0.85 | | 共封装光学(CPO) | 2.23 | 生态农业 | -0.78 | | 特钢概念 | 2.08 | C2 ...

Market Overview - The Chinese medicine sector rose by 1.0% on July 29, with Foci Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3609.71, up 0.33%, while the Shenzhen Component Index closed at 11289.41, up 0.64% [1] Top Gainers in Chinese Medicine Sector - Foci Pharmaceutical (002644) closed at 10.69, up 9.98% with a trading volume of 841,300 shares and a turnover of 876 million yuan [1] - Zhongsheng Pharmaceutical (002317) also rose by 9.98% to 19.73, with a trading volume of 1,168,400 shares and a turnover of 2.26 billion yuan [1] - Other notable gainers include: - Zhendong Pharmaceutical (300158) up 6.66% to 7.69 [1] - Huasen Pharmaceutical (002907) up 6.50% to 18.51 [1] - Kangjia Pharmaceutical (600557) up 5.61% to 16.58 [1] Top Losers in Chinese Medicine Sector - Qidi Pharmaceutical (000590) fell by 2.65% to 12.13, with a trading volume of 134,500 shares and a turnover of 163 million yuan [2] - Zhenbaodao (603567) decreased by 2.21% to 12.40, with a trading volume of 182,700 shares and a turnover of 227 million yuan [2] - Other notable losers include: - Yunnan Baiyao (000538) down 1.20% to 55.82 [2] - Kangmei Pharmaceutical (600518) down 0.94% to 2.10 [2] Capital Flow Analysis - The Chinese medicine sector saw a net inflow of 798 million yuan from institutional investors, while retail investors experienced a net outflow of 625 million yuan [2][3] - Notable net inflows from institutional investors include: - Zhongsheng Pharmaceutical (002317) with a net inflow of 308 million yuan [3] - Zhendong Pharmaceutical (300158) with a net inflow of 96.32 million yuan [3] - Conversely, significant net outflows from retail investors were observed in: - Zhongsheng Pharmaceutical (002317) with a net outflow of 98.88 million yuan [3] - Zhendong Pharmaceutical (300158) with a net outflow of 65.62 million yuan [3]